Aplicare Products, LLC
π¨ Critical Risk
FEI: 1220701 β’ Meriden, CT β’ UNITED STATES
FEI Number
1220701
Location
Meriden, CT
Country
UNITED STATESAddress
550 Research Pkwy, , Meriden, CT, United States
Critical Risk
FDA Import Risk Assessment
This firm has an extensive history of FDA import refusals with severe violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity β AI-assessed (1-10)
- 30% Refusal Volume β Logarithmic scale
- 20% Recency β Decays over 5 years
- 10% Frequency β Refusals per year
Β© ImportRefusal.com Original Analysis
Violation Summary
DRUG GMPS
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the methods used in and controls used for the manufacture, processing, packing, or holding of drugs and other products do not appear to conform to current good manufacturing practices within the meaning of Section 501(a)(2)(B).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
DIRSEXMPT
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 11/17/2025 | 62HBK99ANTI-MICROBIAL N.E.C. | 118NOT LISTED | Division of Southeast Imports (DSEI) |
| 9/11/2025 | 62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL) | 3280FRNMFGREG | Division of Southwest Imports (DSWI) |
| 9/11/2025 | 62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL) | 3280FRNMFGREG | Division of Southwest Imports (DSWI) |
| 9/11/2025 | 62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL) | 3280FRNMFGREG | Division of Southwest Imports (DSWI) |
| 9/11/2025 | 62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL) | 3280FRNMFGREG | Division of Southwest Imports (DSWI) |
| 9/11/2025 | 62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL) | 3280FRNMFGREG | Division of Southwest Imports (DSWI) |
| 9/11/2025 | 62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL) | 3280FRNMFGREG | Division of Southwest Imports (DSWI) |
| 9/11/2025 | 62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL) | 3280FRNMFGREG | Division of Southwest Imports (DSWI) |
| 9/11/2025 | 62HAL05ETHYL ALCOHOL (ANTI-MICROBIAL) | 3280FRNMFGREG | Division of Southwest Imports (DSWI) |
| 5/5/2025 | 80LKBPAD, ALCOHOL, DEVICE DISINFECTANT | 118NOT LISTED | Division of Southwest Imports (DSWI) |
| 10/6/2023 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 2280DIRSEXMPT | Division of West Coast Imports (DWCI) |
| 5/5/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/27/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/21/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/21/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/21/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/20/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/20/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/20/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 4/20/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 2/17/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 2/10/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 2/10/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 2/10/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 2/10/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 2/10/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 2/10/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FCK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FCK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/26/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FCK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
| 1/25/2022 | 62FAK34POVIDONE IODINE (ANTI-INFECTIVE, TOPICAL) | 27DRUG GMPS | Division of Southwest Imports (DSWI) |
Frequently Asked Questions
What is Aplicare Products, LLC's FDA import refusal history?
Aplicare Products, LLC (FEI: 1220701) has 183 FDA import refusal record(s) in our database, spanning from 6/8/2011 to 11/17/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Aplicare Products, LLC's FEI number is 1220701.
What types of violations has Aplicare Products, LLC received?
Aplicare Products, LLC has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Aplicare Products, LLC come from?
All FDA import refusal data for Aplicare Products, LLC is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.